![]() The rise in prevalence of psoriasis around the globe has created a huge demand for safe and effective therapies for the treatment.īiologics or biological therapy is one of the most adopted treatment options. Psoriasis Treatment Market Growth Drivers ![]() (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. Report Scope & Segmentation Report CoverageĪbbVie Inc. Request a Sample Copy of the Research Report: announced the availability of ILUMYA in Canada for the treatment of moderate-to-severe plaque psoriasis to strengthen its presence in Canada. October 2021 - Sun Pharmaceutical Industries Ltd.Additionally, increased focus on biologics by prominent players will foster the market growth. This vital information is presented by Fortune Business Insights™, in its report titled, “Psoriasis Treatment Market, 2022-2029.” Factors, such as rising geriatric population, increasing prevalence of plaque psoriasis, and psoriasis arthritis, will increase the footprint of the market during the forecast period. The market is projected to grow from USD 26.37 billion in 2022 to USD 47.24 billion in 2029 at a CAGR of 8.7% during the 2022-2029 period. 07, 2022 (GLOBE NEWSWIRE) - The psoriasis treatment market size was USD 24.33 billion in 2021.
0 Comments
Leave a Reply. |